论文信息 - Davunetide for progressive supranuclear palsy: Results of the AL-108-231, phase 2/3, 52 week, multi-center, randomized, double-blind, placebo-controlled clinical trial - 字舞流文

Davunetide for progressive supranuclear palsy: Results of the AL-108-231, phase 2/3, 52 week, multi-center, randomized, double-blind, placebo-controlled clinical trial

Andrew J. Lees | Murray Grossman | Anthony E. Lang | Adam L. Boxer | Bruce L. Miller | Michael Gold | David S. Knopman | Rachelle S. Doody | Lon S. Schneider | Joe Hirman | Bruce H. Morimoto | L. Schneider | D. Knopman | M. Grossman | A. Lang | R. Doody | A. Lees | A. Boxer | M. Gold | J. Hirman | B. Miller